A summary of IPOs from companies in the biotech and pharma world since November 1, 2018.
November 2018 IPO Filings and Proceeds, Updated 11/30/18
Know of an IPO since Nov. 1, 2018 that we missed? Email us at news@biospace.com.
Related: Check out BioSpace’s October IPO list here.
| Date | Company Name | Amount (USD) | Company HQ | Research Focus |
|---|---|---|---|---|
| 11/21/18 | Taiwan Liposome Company | $21.8M Priced | Taipei, Taiwan | Lipid-assembled drug delivery platform with approved active pharmaceutical ingredients |
| 11/20/18 | Tiziana Life Sciences Plc | $4.38M Priced | London, UK | Therapeutics and diagnostics for cancers, autoimmune diseases, and inflammation |
| 11/13/18 | Synthorx, Inc. | $100M Filed | La Jolla, CA | Designing and building protein therapeutics to treat cancer and autoimmune disorders |
| 11/13/18 | Vapotherm Inc. | $56M Priced | Exeter, NH | Hi-VNI® technology company for respiratory distress |
| 11/12/18 | Eton Pharmaceuticals | $21.6M Priced | Deer Park, IL | Developing products, that have previously been FDA approved, for new diseases |
| 11/9/18 | Moderna Therapeutics | $500M Filed | Cambridge, MA | mRNA medicines used to eventually prevent, treat, or cure disease |
| 11/9/18 | DiaMedica Therapeutics | $15M Filed | Minneapolis, MN | DM199, a recombinant human protein, for neurological and kidney diseases |
| 11/5/18 | Eton Pharmaceuticals | $21.6M Filed | Deer Park, IL | Developing products, that have previously been FDA approved, for new diseases |
